Table of Contents 1 Hemoglobinopathy Drugs Market Overview 1.1 Product Overview and Scope of Hemoglobinopathy Drugs 1.2 Classification of Hemoglobinopathy Drugs by Types 1.2.1 Global Hemoglobinopathy Drugs Revenue Comparison by Types (2019-2024) 1.2.2 Global Hemoglobinopathy Drugs Revenue Market Share by Types in 2018 1.2.3 Hydroxyurea 1.2.4 Glutamine 1.2.5 Zynteglo 1.2.6 Other 1.3 Global Hemoglobinopathy Drugs Market by Application 1.3.1 Global Hemoglobinopathy Drugs Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Sickle Cell Diseases 1.3.3 Thalassemia 1.4 Global Hemoglobinopathy Drugs Market by Regions 1.4.1 Global Hemoglobinopathy Drugs Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Hemoglobinopathy Drugs Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Hemoglobinopathy Drugs Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemoglobinopathy Drugs Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Hemoglobinopathy Drugs Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemoglobinopathy Drugs Status and Prospect (2014-2024) 1.5 Global Market Size of Hemoglobinopathy Drugs (2014-2024) 2 Company Profiles 2.1 Novartis 2.1.1 Business Overview 2.1.2 Hemoglobinopathy Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Novartis Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.2 Eli Lilly and Company 2.2.1 Business Overview 2.2.2 Hemoglobinopathy Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Eli Lilly and Company Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.3 Bristol-Myers Squibb 2.3.1 Business Overview 2.3.2 Hemoglobinopathy Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.4 AstraZeneca 2.4.1 Business Overview 2.4.2 Hemoglobinopathy Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 AstraZeneca Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.5 HemaQuest Pharmaceuticals 2.5.1 Business Overview 2.5.2 Hemoglobinopathy Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.6 Bluebird 2.6.1 Business Overview 2.6.2 Hemoglobinopathy Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Bluebird Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.7 Acceleron Pharma 2.7.1 Business Overview 2.7.2 Hemoglobinopathy Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Acceleron Pharma Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.8 Emmaus Medical 2.8.1 Business Overview 2.8.2 Hemoglobinopathy Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Emmaus Medical Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.9 Celgene 2.9.1 Business Overview 2.9.2 Hemoglobinopathy Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Celgene Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) 3 Global Hemoglobinopathy Drugs Market Competition, by Players 3.1 Global Hemoglobinopathy Drugs Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Hemoglobinopathy Drugs Players Market Share 3.2.2 Top 10 Hemoglobinopathy Drugs Players Market Share 3.3 Market Competition Trend 4 Global Hemoglobinopathy Drugs Market Size by Regions 4.1 Global Hemoglobinopathy Drugs Revenue and Market Share by Regions 4.2 North America Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 4.3 Europe Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 4.5 South America Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 5 North America Hemoglobinopathy Drugs Revenue by Countries 5.1 North America Hemoglobinopathy Drugs Revenue by Countries (2014-2019) 5.2 USA Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 5.3 Canada Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 5.4 Mexico Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 6 Europe Hemoglobinopathy Drugs Revenue by Countries 6.1 Europe Hemoglobinopathy Drugs Revenue by Countries (2014-2019) 6.2 Germany Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 6.3 UK Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 6.4 France Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 6.5 Russia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 6.6 Italy Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Hemoglobinopathy Drugs Revenue by Countries 7.1 Asia-Pacific Hemoglobinopathy Drugs Revenue by Countries (2014-2019) 7.2 China Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 7.3 Japan Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 7.4 Korea Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 7.5 India Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 8 South America Hemoglobinopathy Drugs Revenue by Countries 8.1 South America Hemoglobinopathy Drugs Revenue by Countries (2014-2019) 8.2 Brazil Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 8.3 Argentina Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 8.4 Colombia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Hemoglobinopathy Drugs by Countries 9.1 Middle East and Africa Hemoglobinopathy Drugs Revenue by Countries (2014-2019) 9.2 Saudi Arabia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 9.3 UAE Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 9.4 Egypt Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 9.5 Nigeria Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 9.6 South Africa Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) 10 Global Hemoglobinopathy Drugs Market Segment by Type 10.1 Global Hemoglobinopathy Drugs Revenue and Market Share by Type (2014-2019) 10.2 Global Hemoglobinopathy Drugs Market Forecast by Type (2019-2024) 10.3 Hydroxyurea Revenue Growth Rate (2014-2024) 10.4 Glutamine Revenue Growth Rate (2014-2024) 10.5 Zynteglo Revenue Growth Rate (2014-2024) 10.6 Other Revenue Growth Rate (2014-2024) 11 Global Hemoglobinopathy Drugs Market Segment by Application 11.1 Global Hemoglobinopathy Drugs Revenue Market Share by Application (2014-2019) 11.2 Hemoglobinopathy Drugs Market Forecast by Application (2019-2024) 11.3 Sickle Cell Diseases Revenue Growth (2014-2019) 11.4 Thalassemia Revenue Growth (2014-2019) 12 Global Hemoglobinopathy Drugs Market Size Forecast (2019-2024) 12.1 Global Hemoglobinopathy Drugs Market Size Forecast (2019-2024) 12.2 Global Hemoglobinopathy Drugs Market Forecast by Regions (2019-2024) 12.3 North America Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) 12.4 Europe Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) 12.6 South America Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Hemoglobinopathy Drugs Picture Table Product Specifications of Hemoglobinopathy Drugs Table Global Hemoglobinopathy Drugs and Revenue (Million USD) Market Split by Product Type Figure Global Hemoglobinopathy Drugs Revenue Market Share by Types in 2018 Figure Hydroxyurea Picture Figure Glutamine Picture Figure Zynteglo Picture Figure Other Picture Table Global Hemoglobinopathy Drugs Revenue (Million USD) by Application (2014-2024) Figure Hemoglobinopathy Drugs Revenue Market Share by Applications in 2018 Figure Sickle Cell Diseases Picture Figure Thalassemia Picture Table Global Market Hemoglobinopathy Drugs Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (2014-2024) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Hemoglobinopathy Drugs Type and Applications Table Novartis Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Hemoglobinopathy Drugs Type and Applications Table Eli Lilly and Company Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Hemoglobinopathy Drugs Type and Applications Table Bristol-Myers Squibb Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Hemoglobinopathy Drugs Type and Applications Table AstraZeneca Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table HemaQuest Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Type and Applications Table HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Bluebird Basic Information, Manufacturing Base and Competitors Table Bluebird Hemoglobinopathy Drugs Type and Applications Table Bluebird Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Acceleron Pharma Basic Information, Manufacturing Base and Competitors Table Acceleron Pharma Hemoglobinopathy Drugs Type and Applications Table Acceleron Pharma Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Emmaus Medical Basic Information, Manufacturing Base and Competitors Table Emmaus Medical Hemoglobinopathy Drugs Type and Applications Table Emmaus Medical Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene Hemoglobinopathy Drugs Type and Applications Table Celgene Hemoglobinopathy Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Global Hemoglobinopathy Drugs Revenue (Million USD) by Players (2014-2019) Table Global Hemoglobinopathy Drugs Revenue Share by Players (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Share by Players in 2017 Figure Global Hemoglobinopathy Drugs Revenue Share by Players in 2018 Figure Global Top 5 Players Hemoglobinopathy Drugs Revenue Market Share in 2018 Figure Global Top 10 Players Hemoglobinopathy Drugs Revenue Market Share in 2018 Figure Global Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Hemoglobinopathy Drugs Revenue (Million USD) by Regions (2014-2019) Table Global Hemoglobinopathy Drugs Revenue Market Share by Regions (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Market Share by Regions (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Market Share by Regions in 2018 Figure North America Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Europe Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure South America Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table North America Hemoglobinopathy Drugs Revenue by Countries (2014-2019) Table North America Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure North America Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure North America Hemoglobinopathy Drugs Revenue Market Share by Countries in 2018 Figure USA Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Canada Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Mexico Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table Europe Hemoglobinopathy Drugs Revenue (Million USD) by Countries (2014-2019) Figure Europe Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure Europe Hemoglobinopathy Drugs Revenue Market Share by Countries in 2018 Figure Germany Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure UK Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure France Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Russia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Italy Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table Asia-Pacific Hemoglobinopathy Drugs Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Hemoglobinopathy Drugs Revenue Market Share by Countries in 2018 Figure China Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Japan Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Korea Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure India Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Southeast Asia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table South America Hemoglobinopathy Drugs Revenue by Countries (2014-2019) Table South America Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure South America Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure South America Hemoglobinopathy Drugs Revenue Market Share by Countries in 2018 Figure Brazil Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Argentina Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Colombia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table Middle East and Africa Hemoglobinopathy Drugs Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Hemoglobinopathy Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Hemoglobinopathy Drugs Revenue Market Share by Countries in 2018 Figure Saudi Arabia Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure UAE Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Egypt Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure Nigeria Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Figure South Africa Hemoglobinopathy Drugs Revenue and Growth Rate (2014-2019) Table Global Hemoglobinopathy Drugs Revenue (Million USD) by Type (2014-2019) Table Global Hemoglobinopathy Drugs Revenue Share by Type (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Share by Type (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Share by Type in 2018 Table Global Hemoglobinopathy Drugs Revenue Forecast by Type (2019-2024) Figure Global Hemoglobinopathy Drugs Market Share Forecast by Type (2019-2024) Figure Global Hydroxyurea Revenue Growth Rate (2014-2019) Figure Global Glutamine Revenue Growth Rate (2014-2019) Figure Global Zynteglo Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Table Global Hemoglobinopathy Drugs Revenue by Application (2014-2019) Table Global Hemoglobinopathy Drugs Revenue Share by Application (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Share by Application (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue Share by Application in 2018 Table Global Hemoglobinopathy Drugs Revenue Forecast by Application (2019-2024) Figure Global Hemoglobinopathy Drugs Market Share Forecast by Application (2019-2024) Figure Global Sickle Cell Diseases Revenue Growth Rate (2014-2019) Figure Global Thalassemia Revenue Growth Rate (2014-2019) Figure Global Hemoglobinopathy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Hemoglobinopathy Drugs Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Hemoglobinopathy Drugs Revenue Market Share Forecast by Regions (2019-2024) Figure North America Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) Figure Europe Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) Figure Asia-Pacific Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) Figure South America Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024) Figure Middle East and Africa Hemoglobinopathy Drugs Revenue Market Forecast (2019-2024)

Novartis Eli Lilly and Company Bristol-Myers Squibb AstraZeneca HemaQuest Pharmaceuticals Bluebird Acceleron Pharma Emmaus Medical Celgene